Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu Arun

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Molecular Cancer Therapeutics|April 29, 2010
Targeting p70S6K prevented lung metastasis in a breast cancer xenograft modelUgur Akar, Bulent Ozpolat, Kapil Mehta, et al.
Breast Cancer Research and Treatment|May 22, 2013
Simplifying clinical use of the genetic risk prediction model BRCAPROSwati Biswas, Philamer Atienza, Jonathan Chipman, et al.
Journal of the Society for Integrative Oncology|April 15, 2010
Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancerKavita D Chandwani, Bob Thornton, George H Perkins, et al.
Journal of Community Genetics|January 22, 2021
Disclosure of familial implications of pathogenic variants in breast-cancer genes to patients: Opportunity for prompting family communicationSukh Makhnoon, Hadley S Smith, Erica M Bednar, et al.
Nanomedicine (London, England)|August 22, 2019
EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses <i>BRCA1</i>-mutated breast cancerElif Asik, Yeliz Akpinar, Ayse Caner, et al.
Journal of Cancer|April 12, 2014
Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the LiteraturePamela Abdayem, Marwan Ghosn, Vicente Valero, et al.
Breast (Edinburgh, Scotland)|September 19, 2014
Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or lessSoley Bayraktar, Laura Amendola, Angelica M Gutierrez-Barrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Expanding the criteria for BRCA mutation testing in breast cancer survivorsJanice S Kwon, Angelica M Gutierrez-Barrera, Diana Young, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 9, 2008
Loss of annexin A1 expression in breast cancer progressionYing Cao, Yong Li, Marcia Edelweiss, et al.
Cancer|August 16, 2006
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinomaEdgardo Rivera, Christina Meyers, Morris Groves, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Molecular Cancer Therapeutics|April 29, 2010
Targeting p70S6K prevented lung metastasis in a breast cancer xenograft modelUgur Akar, Bulent Ozpolat, Kapil Mehta, et al.
Breast Cancer Research and Treatment|May 22, 2013
Simplifying clinical use of the genetic risk prediction model BRCAPROSwati Biswas, Philamer Atienza, Jonathan Chipman, et al.
Journal of the Society for Integrative Oncology|April 15, 2010
Yoga improves quality of life and benefit finding in women undergoing radiotherapy for breast cancerKavita D Chandwani, Bob Thornton, George H Perkins, et al.
Journal of Community Genetics|January 22, 2021
Disclosure of familial implications of pathogenic variants in breast-cancer genes to patients: Opportunity for prompting family communicationSukh Makhnoon, Hadley S Smith, Erica M Bednar, et al.
Nanomedicine (London, England)|August 22, 2019
EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses <i>BRCA1</i>-mutated breast cancerElif Asik, Yeliz Akpinar, Ayse Caner, et al.
Journal of Cancer|April 12, 2014
Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the LiteraturePamela Abdayem, Marwan Ghosn, Vicente Valero, et al.
Breast (Edinburgh, Scotland)|September 19, 2014
Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or lessSoley Bayraktar, Laura Amendola, Angelica M Gutierrez-Barrera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Expanding the criteria for BRCA mutation testing in breast cancer survivorsJanice S Kwon, Angelica M Gutierrez-Barrera, Diana Young, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 9, 2008
Loss of annexin A1 expression in breast cancer progressionYing Cao, Yong Li, Marcia Edelweiss, et al.
Cancer|August 16, 2006
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinomaEdgardo Rivera, Christina Meyers, Morris Groves, et al.
Pageof 18